It does matter

Nursing for Women's Health

Volumn 14, Issue 1, 2010, Pages 34-41

  Holt, Karyn ^a  

^a DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST TUMOR; CANCER INVASION; CLASSIFICATION; FEMALE; HUMAN; LUNG CARCINOMA; MALE; MORTALITY; NURSE ATTITUDE; NURSING; PAGET NIPPLE DISEASE; PATHOLOGY; PROGNOSIS; RISK FACTOR; TREATMENT OUTCOME;

BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MALE; NEOPLASM INVASIVENESS; NURSE'S ROLE; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 76349113841     PISSN: 17514851     EISSN: 1751486X     Source Type: Journal    
DOI: 10.1111/j.1751-486X.2010.01505.x     Document Type: Article

References (51)

1. Afonso N, Bouwman D. Lobular carcinoma in situ. European Journal of Cancer Prevention 2008, 17((4)):312-316.
2. Ahern T, Lash T, Egan K, Baron J. Lifetime tobacco smoke exposure and breast cancer incidence. Cancer Causes and Control 2009, 20:1837-1844.
3. Al Sayed A, El Weshi A, Tulbah A, Rahal M, Ezzat A. Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncologica 2006, 45((2)):188-195.
4. 2008, http://www.cancer.org/downloads/STT/BCFF-Final.pdf, American Cancer Society., Retrieved from
5. Arpino G, Bardou V, Clark G, Elledge R. Infiltrating lobular carcinoma of the breast: Tumor characteristics and clinical outcome. Breast Cancer Research 2004, 6((3)):R149-R156.
6. Bollet M, Savignoni A, Pierga J, Lae M, Fourchotte V, Kirova Y. High rates of breast conservation for large ductal and lobular invasive carcinomas combining multimodality strategies. British Journal of Cancer 2008, 98((4)):734-741.
7. 2008a, http://www.breastcancer.org/symptoms/types/idc/, Breastcancer.org., Retrieved from
8. 2008b, http://www.breastcancer.org/symptoms/types/rare_idc/, Breastcancer.org., Retrieved from
9. Butow P, Harrison J, Choy E, Young J, Spillane A, Evans A. Health professional and consumer views on involving breast cancer patients in the multidisciplinary discussion of their disease and treatment plan. Cancer 2007, 110((9)):1937-1944.
10. Cabral A, Recine M, Paramo J, McPhee M, Poppiti R, Mesko T. Tubular carcinoma of the breast: An institutional experience and review of the literature. Breast Journal 2003, 9((4)):298-301.
11. Capella C, Eusebi V, Mann B, Azzopardi J. Endocrine differentiation in mucoid carcinoma of the breast. Histopathology 1980, 4((6)):613-630.
12. Carmichael A, Bates T. Obesity and breast cancer: A review of the literature. Breast 2004, 13((2)):85-92.
13. Chang Y, Kwon K, Lee D. Synchronous bilateral mucinous carcinoma of the breast: Case report. Clinical Imaging 2009, 33((1)):62-66.
14. Clayton F. Pure mucinous carcinomas of breast: Morphologic features and prognostic correlates. Human Pathology 1986, 17((1)):34-38.
15. Cleary M P. Obesity and breast cancer: The estrogen connection. Endocrinology 2009, 150((6)):2537-2542.
16. Cristofanilli M, Valero V, Buzdar A, Kau S, Broglio K, Gonzalez-Angulo A. Inflammatory breast cancer (IBC) and patterns of recurrence: Understanding the biology of a unique disease. Cancer 2007, 110((7)):1436-1444.
17. Cutuli B, Lemanski C, Fourquet A, de Lafontan B, Giard S, Meunier A. Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French survey experience. British Journal of Cancer 2009, 100((7)):1048-1054.
18. Day S. Clear and present danger: Management of women with LCIS. Advanced Nurse Practitioner 2008, 16((10)):49-53.
19. Dean A. Primary breast cancer: Risk factors, diagnosis and management. Nursing Standard 2008, 22((40)):47-55. quiz 58, 60
20. Dian D, Herold H, Mylonas I, Scholz C, Janni W, Sommer H. Survival analysis between patients with invasive ductal and invasive lobular breast cancer. Archives of Gynecology and Obstetrics 2009, 279((1)):23-28.
21. Di Saverio S, Gutierrez J, Avisar E. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Breast Cancer Research and Treatment 2008, 111((3)):541-547.
22. Eheman C, Shaw K, Ryerson A, Miller J, Ajani U, White M. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004. Cancer Epidemiological Biomarkers and Prevention 2009, 18((6)):1763-1769.
23. Finke E, Light J, Kitko L. A systematic review of the effectiveness of nurse communication with patients with complex communication needs with a focus on the use of augmentative and alternative communication. Journal of Clinical Nursing 2008, 17((16)):2102-2115.
24. Franceschini G, Terribile D, Magno S, Fabbri C, D'Alba P, Chiesa F. Current controversies in the treatment of ductal carcinoma in situ of the breast. Annali Italiani di Chirurgia 2008, 79((3)):151-155.
25. Gajalakshmi V, Mathew A, Brennan P, Rajan B, Kanimozhi V, Mathews A. Breastfeeding and breast cancer risk in India: A multicenter case-control study. International Journal of Cancer 2009, 125((3)):662-665.
26. Goodwin A, Parker S, Ghersi D, Wilcken N. 2009, Post-operative radiotherapy for ductal carcinoma in situ of the breast. , CD000563
27. Günhan-Bilgen I, Oktay A. Tubular carcinoma of the breast: Mammographic, sonographic, clinical and pathologic findings. European Journal of Radiology 2007, 61((1)):158-162.
28. Hanby A, Hughes T. In situ and invasive lobular neoplasia of the breast. Histopathology 2008, 52((1)):58-66.
29. Ho B, Tan P. Lobular neoplasia of the breast: 68 years on. Pathology 2009, 41((1)):28-35.
30. Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A. Trends in hormone therapy and breast cancer incidence-results from the German network of Cancer registries. Pathobiology 2009, 76((2)):90-97.
31. Knight J, Bernstein L, Largent J, Capanu M, Begg C, Mellemkjaer L. Alcohol intake and cigarette smoking and risk of a contralateral breast cancer: The Women's Environmental Cancer and Radiation Epidemiology Study. American Journal of Epidemiology 2009, 169((8)):962-968.
32. Levine P, Veneroso C. The epidemiology of inflammatory breast cancer. Seminars in Oncology 2008, 35((1)):11-16.
33. Li C, Daling J, Malone K, Bernstein L, Marchbanks P, Liff J. Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer. Cancer Epidemiology Biomarkers and Prevention 2006, 15((5)):946-954.
34. Louwman M, Vriezen M, van Beek M, Nolthenius-Puylaert M, van der Sangen M, Roumen R. Uncommon breast tumors in perspective: Incidence, treatment and survival in the Netherlands. International Journal of Cancer 2007, 121((1)):127-135.
35. Luini A, Aguilar M, Gatti G, Fasani R, Botteri E, Brito J. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: The experience of the European Institute of Oncology and review of the literature. Breast Cancer Research and Treament 2007, 101((3)):349-353.
36. Luth J, ubbard G, Dick E J, Frazier S, Barrier B. Characterization of spontaneous mammary gland carcinomas in female baboons. Journal of Medical Primatology 2008, 37((1)):55-61.
37. Maass N, Alkasi O, Bauer M, Jonat W, Souchon R, Meinhold-Heerlein I. Actual management of ductal carcinoma in situ of the breast. Archives of Gynecology and Obstetrics 2009, 280((5)):699-705.
38. Matsuno R, Anderson W, Yamamoto S, Tsukuma H, Pfeiffer R, Kobayashi K. Early- and late-onset breast cancer types among women in the United States and Japan. Cancer Epidemiologic Biomarkers and Prevention 2007, 16((7)):1437-1442.
39. Nassar H, Sharafaldeen B, Visvanathan K, Visscher D. Ductal carcinoma in situ in African American versus Caucasian American women: Analysis of clinicopathologic features and outcome. Cancer 2009, 115((14)):3181-3188.
40. Panades M, Olivotto I, Speers C, Shenkier T, Olivotto T, Weir L. Evolving treatment strategies for inflammatory breast cancer: A population-based survival analysis. Journal of Clinical Oncology 2005, 23((9)):1941-1950.
41. Park S, Kim J, Koo J, Park B, Lee K. linicopathological characteristics of male breast cancer. Yonsei Medical Journal 2008, 49((6)):978-986.
42. Pérez-López F R, Chedraui P, Gilbert J J, Pérez-Roncero G. Cardiovascular risk in menopausal women and prevalent co-morbid conditions: Facing the post-Women's Health Inititative era. Fertility and Sterility 2009, 92((4)):1171-1186.
43. Pestalozzi B, Zahrieh D, Mallon E, Gusterson B, Price K, Gelber R. Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: Combined results of 15 International Breast Cancer Study Group clinical trials. Journal of Clinical Oncology 2008, 26((18)):3006-3014.
44. Rauf F, Kiyani N, Bhurgri Y. Metaplastic carcinoma of the breast, an intriguing rarity. Asian Pacific Journal of Cancer Prevention 2006, 7((4)):667-671.
45. Reigle B, Wonders K. Breast cancer and the role of exercise in women. Methods of Molecular Biology 2009, 472:169-189.
46. Robinson D, Holmberg L, Møller H. The occurrence of invasive cancers following a diagnosis of breast carcinoma in situ. British Journal of Cancer 2008, 99((4)):611-615.
47. Silvera D, Arju R, Darvishian F, Levine P, Zolfaghari L, Goldberg J. Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nature Cell Biology 2009, 11:903-908.
48. Sullivan T, Raad R, Goldberg S, Assaad S, Gadd M, Smith B. Tubular carcinoma of the breast: A retrospective analysis and review of the literature. Breast Cancer Research and Treatment 2005, 93((3)):199-205.
49. Vachon C, van Gils C, Sellers T, Ghosh K, Pruthi S, Brandt K. Mammographic density, breast cancer risk and risk prediction. Breast Cancer Research 2007, 9((6)):217.
50. Valenzuela M, Julian T. Ductal carcinoma in situ: Biology, diagnosis, and new therapies. Clinical Breast Cancer 2007, 7((9)):676-681.
51. Yoney A, Kucuk A, Unsal M. Male breast cancer: A retrospective analysis. Cancer Radiotherapy 2009, 13((2)):103-107.